Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Guidance on the use of read-across for chemical safety assessment in food and feed. | EFSA J | 2025 | 40726815 | PubTator, text mining | PubMed |
| MASLD/MASH-New mechanisms and treatments. | Hepatol Commun | 2025 | 40694379 | PubTator, text mining | PubMed |
| Legacy hERG study data in contemporary integrated risk assessments - mitigating the risk of protocol and positive control article differences. | J Pharmacol Toxicol Methods | 2025 | 40683363 | PubTator, text mining | PubMed |
| Whole Genome Sequencing of "Mutation-Negative" Individuals With Cornelia de Lange Syndrome. | Hum Mutat | 2025 | 40677927 | PubTator, text mining | PubMed |
| Unveiling the Role of Histone Methyltransferases in Psoriasis Pathogenesis: Insights from Transcriptomic Analysis. | Int J Mol Sci | 2025 | 40650108 | PubTator, text mining | PubMed |
| Development of a Patient and Caregiver-Centered Pediatric Disease Concept Model for Kleefstra Syndrome. | Sage Open Pediatr | 2025 | 40612157 | PubTator, text mining | PubMed |
| Incidental detection of a familial 361-kb 9q34.3 microduplication encompassing EHMT1 and CACNA1B without apparently phenotypic abnormality. | Taiwan J Obstet Gynecol | 2025 | 40602976 | PubTator, text mining | PubMed |
| Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus. | Diabetes Ther | 2025 | 40542226 | PubTator, text mining | PubMed |
| The SUV39 Family of H3K9 Methyltransferases in Skeletal Muscle Stem Cells. | FASEB Bioadv | 2025 | 40496353 | PubTator, text mining | PubMed |
| Untangling hidden players of PCOS: From transcriptomics to key biomarkers using WGCNA, LASSO and ROC analysis. | J Steroid Biochem Mol Biol | 2025 | 40480394 | PubTator, text mining | PubMed |
| EHMT1 mediates cellular motility in embryonal rhabdomyosarcoma by activating SOX8 expression. | Br J Cancer | 2025 | 40467997 | PubTator, text mining | PubMed |
| Artificial Intelligence in Veterinary Clinical Pathology-An Introduction and Review. | Vet Clin Pathol | 2025 | 40462415 | PubTator, text mining | PubMed |
| Digital Pathology and Artificial Intelligence Applied to Nonclinical Toxicology Pathology-The Current State, Challenges, and Future Directions. | Toxicol Pathol | 2025 | 40459370 | PubTator, text mining | PubMed |
| A Novel Frameshift Variant and a Partial EHMT1 Microdeletion in Kleefstra Syndrome 1 Patients Resulting in Variable Phenotypic Severity and Literature Review. | Genes (Basel) | 2025 | 40428343 | PubTator, text mining | PubMed |
| Off-label GLP-1 weight-loss medicine use among online bodybuilders: Folk pharmacology, risk and harm reduction. | Int J Drug Policy | 2025 | 40418873 | PubTator, text mining | PubMed |
| Comprehensive Evaluation of the Bioactives of Elaeagnus umbellata for Their Antidiabetic Potential Using In Vitro and In Silico Approaches. | Chem Biodivers | 2025 | 40418827 | PubTator, text mining | PubMed |
| A new association between Kleefstra syndrome and Panayiotopoulos epilepsy. | Ital J Pediatr | 2025 | 40394668 | PubTator, text mining | PubMed |
| Identification, validation, and characterization of approved and investigational drugs interfering with the SARS-CoV-2 endoribonuclease Nsp15. | Protein Sci | 2025 | 40371758 | PubTator, text mining | PubMed |
| Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectives. | Front Immunol | 2025 | 40370464 | PubTator, text mining | PubMed |
| Evaluation of health laboratory ethical compliance among laboratory practitioners in Kinondoni District, Tanzania. | BMC Health Serv Res | 2025 | 40241077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=5